Interestingly, we found that TRF partially restored the MCDD-induced reduction in IPMK protein and significantly improved pro-inflammatory chemokine gene expression, suggesting that IPMK may play a causal role in the progression of NAFLD/NASH. This evidence concerns the gene IPMK and metabolic dysfunction-associated steatotic liver disease.